MedPath

LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER-NEW ORLEANS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis

Phase 2
Withdrawn
Conditions
Multiple Sclerosis
Interventions
Drug: 95% Pure ECGC capsules 200mg
First Posted Date
2013-12-13
Last Posted Date
2016-09-26
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Registration Number
NCT02011451
Locations
🇺🇸

LSU Health Sciences Center, New Orleans, Louisiana, United States

Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients

Phase 2
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Placebo
Drug: Inhaled iloprost 5.0 mcg
First Posted Date
2013-09-13
Last Posted Date
2016-12-16
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
24
Registration Number
NCT01941225
Locations
🇺🇸

LSU Health Sciences Center, New Orleans, Louisiana, United States

Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II

Phase 2
Terminated
Conditions
Multiple Sclerosis
Interventions
Other: Placebo
First Posted Date
2011-10-14
Last Posted Date
2014-03-14
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
11
Registration Number
NCT01451723
Locations
🇺🇸

LSu Health Sciences Center, New Orleans, Louisiana, United States

Strength Training Induced Alterations in Markers of Immune Function

Not Applicable
Completed
Conditions
Inflammation
Interventions
Behavioral: Strength Training
First Posted Date
2011-10-12
Last Posted Date
2011-10-12
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
42
Registration Number
NCT01450852
Locations
🇺🇸

Louisiana State University, Baton Rouge, Louisiana, United States

Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites

Phase 3
Completed
Conditions
Dental Caries
Interventions
Procedure: Dental Implant
First Posted Date
2010-11-22
Last Posted Date
2010-11-22
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
75
Registration Number
NCT01244997
Locations
🇺🇸

LSU School of Dentistry, New Orleans, Louisiana, United States

Lamotrigine Augmentation in Resistant Depression

Not Applicable
Completed
Conditions
Unipolar Depression
Interventions
First Posted Date
2009-05-13
Last Posted Date
2009-05-13
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
138
Registration Number
NCT00901407
Locations
🇺🇸

LSUHSC- New Orleans, New Orleans, Louisiana, United States

Safety of Polyphenon E in Multiple Sclerosis Pilot Study

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2009-02-04
Last Posted Date
2013-06-27
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
10
Registration Number
NCT00836719
Locations
🇺🇸

Louisiana Health Sciences Center New Orleans, New Orleans, Louisiana, United States

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2008-11-04
Last Posted Date
2012-06-20
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
62
Registration Number
NCT00784849
Locations
🇺🇸

University Medical Center, Lafayette, Louisiana, United States

🇺🇸

LSU Interim Hospital, New Orleans, Louisiana, United States

Autologous Fat Grafting to the Breast

Not Applicable
Conditions
Micromastia
Breast Ptosis
Implant Failure
Breast Reconstruction
Congenital Malformations
Interventions
Procedure: Autologous Fat Grafting to Breasts
First Posted Date
2008-10-20
Last Posted Date
2008-11-18
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
50
Registration Number
NCT00775788
Locations
🇺🇸

Houma Outpatient Surgery Center, Metairie, Louisiana, United States

🇺🇸

Medical Center of Louisiana New Orleans, LSU Health Sciences Center, New Orleans, Louisiana, United States

Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors

Phase 2
Completed
Conditions
Metastatic Neuroendocrine Tumors
Interventions
First Posted Date
2008-01-10
Last Posted Date
2011-06-29
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
23
Registration Number
NCT00590343
Locations
🇺🇸

Neuroendocrine Clinic, Kenner, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath